董秘回答(广信材料SZ300537)： 据了解，截至目前在PCB光刻胶、显示光刻胶、集成电路光刻胶等传统光刻胶主流供应商仍以日韩企业 为主，其中国产化率最高的PCB光刻胶依旧有一半以上市场份额仍被日资企业占领，存在很大替代空 间。经过多年的发展，公司在光刻胶板块以PCB光刻胶为基本盘稳健增长、适时拓展光伏胶等泛半导体 领域，目前已成为PCB光刻胶领域内资头部企业、光伏胶等泛半导体领域领跑企业。随着公司龙南基地 已经逐步试生产及公司产能资产进一步优化，经营水平、研发水平、市场开拓的不断提升，将进一步支 撑公司在相关领域的业务增长！感谢您的关注！查看更多董秘问答>> 投资者提问： 你好，请问公司旗下是否有日本卡脖子的半导体材料国产替代能力？ 免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确 性，内容仅供参考。 ...

Core Insights - The company, Aisen Co., Ltd. (688725.SH), has achieved a significant breakthrough in the domestic production of ultra-pure cobalt sulfate solution, receiving its first mass production order from a mainstream wafer manufacturer [1][3] - Aisen has made notable progress in the research and industrialization of advanced process technology, successfully supplying core materials for mainstream wafer manufacturers at 28nm and 5nm-14nm process nodes [3] - The ultra-pure cobalt sulfate solution's mass production enhances the self-sufficiency of the domestic semiconductor material supply chain and indicates a gradual break from foreign technology monopolies in high-end electronic chemicals [3] Company Developments - Aisen's core product lines include copper plating additives and ultra-pure chemicals, with copper additives already receiving stable mass production orders from several leading wafer manufacturers [3] - The company is one of the few in China capable of providing key material solutions for process nodes of 5nm and below, with its products widely used in wafer manufacturing, packaging testing, and high-end display panels [3] Industry Impact - The successful domestic mass production of ultra-pure cobalt sulfate solution is expected to accelerate the process of domestic substitution for semiconductor materials in China [3]

Core Viewpoint - Fujian Del Technology Co., Ltd. has withdrawn its IPO application after two years, halting its ambition to become the first fluorine materials company listed in Fujian, with a previous valuation of 17 billion yuan [1][8]. Group 1: Company Overview - Fujian Del is recognized as a "hard technology unicorn" in the semiconductor materials sector, with significant innovations in fluorine electronic materials and 305 domestic and 6 foreign invention patents [3]. - The company is classified as a national-level specialized and innovative "little giant" [3]. Group 2: Shareholding Structure - The largest shareholder, Lai Zongming, holds 15.60% of the shares, with no single shareholder owning more than 50%. The actual controllers are Lai Zongming, Hua Xiangbin, and Huang Tianliang, collectively controlling 35.06% of voting rights [5]. Group 3: IPO Journey and Financial Performance - The IPO application was accepted in June 2023, aiming to raise 1.945 billion yuan, but was voluntarily withdrawn in August 2025 due to financial performance concerns [8][10]. - Financial data shows significant revenue fluctuations and a sharp decline in net profit: revenue dropped from 1.698 billion yuan in 2022 to 1.418 billion yuan in 2023 (a 16.5% decrease), and net profit fell from 221 million yuan to 119 million yuan (a 46% decrease) [8][9]. - Although net profit rebounded to 131 million yuan in 2024, it remained below 2022 levels, raising questions about the company's stability and growth potential during the IPO review process [8][10]. Group 4: Regulatory Environment - In April 2024, the Shanghai Stock Exchange raised the listing threshold, requiring a cumulative net cash flow of at least 250 million yuan over three years for companies applying under the second set of standards, which Fujian Del had to meet [10]. Group 5: Future Prospects - Industry observers suggest that the withdrawal allows the company to avoid negative impacts from a potential rejection and provides time for strategic adjustments, such as improving financial metrics or exploring alternative financing options [11]. - There is potential for Fujian Del to refocus on higher-margin semiconductor materials and possibly consider listing on the Sci-Tech Innovation Board or Hong Kong stock market in the future [13].

Core Viewpoint - Del Technology, a fluorochemical company, is facing significant challenges as it prepares for its IPO, with declining profits and a reduced fundraising target, indicating a critical juncture in its business transformation [1][3][22]. Financial Performance - The company's net profit attributable to shareholders has declined for three consecutive years, from 303 million yuan in 2021 to 119 million yuan in 2023, with only 64.01 million yuan in the first half of 2024 [3][5]. - The adjusted net profit after excluding non-recurring gains and losses dropped from 184 million yuan in 2022 to 86 million yuan in 2024, a decline of over 50% [5]. - The total assets increased from 5.36 billion yuan in 2022 to 6.86 billion yuan in 2024, while the total revenue showed a decrease from 1.70 billion yuan in 2022 to 1.69 billion yuan in 2024 [6][20]. IPO and Fundraising - The IPO fundraising target has been significantly reduced from 3 billion yuan to 1.945 billion yuan, a decrease of 35% [4][9]. - The number of fundraising projects has been cut from seven to three, with all projects related to new energy materials removed [4][9]. Business Transformation - The company is shifting its focus towards semiconductor materials, with revenue from this segment exceeding 50% in the first half of 2024 [7]. - The reliance on lithium hexafluorophosphate, which previously accounted for 38% of revenue, has diminished, with its contribution dropping to 4.28% in 2024 [5][7]. Research and Development - The company's R&D expenditure ratio has been low, ranging from 1.84% to 2.24% from 2022 to 2024, significantly below the industry average of 5.11% to 5.46% [12][15]. - The company claims that the low R&D demand in its fluorochemical materials business justifies the reduced investment, but this raises concerns about its long-term technological competitiveness [12][15]. Governance Issues - The three actual controllers of the company hold only 35.06% of the shares, which may lead to control risks post-IPO due to further dilution of voting rights [16][17]. - Historical issues with shareholding representation have raised concerns about the clarity of ownership, particularly with recent shareholding changes before the IPO application [17][18]. Financial Anomalies - In 2023, despite a 16.52% decline in revenue, accounts receivable increased by 49.83%, raising questions about the reasonableness of revenue recognition [19]. - The gross profit margin has decreased from 29.75% in 2022 to 16.04% in 2024, indicating weakened profitability [19][20]. Market Outlook - The company’s IPO journey has faced multiple challenges, with its status shifting from "suspended" to "inquiry" after financial updates [22]. - The semiconductor materials market is expected to grow at an annual rate of over 15%, but the company’s performance remains highly dependent on the semiconductor industry cycle [8][24].

Group 1 - The report emphasizes the importance of supply shocks and is optimistic about the import substitution of new materials in the basic chemical industry [1][4] - The chemical raw materials and products industry achieved revenue and profit of 2.95 trillion and 115 billion respectively in the first four months of 2025, with a year-on-year growth of 3.1% and a profit decline of 4.4% [12][19] - The chemical industry profit margin has dropped to a historical low of 3.9% as of mid-2025 [12][52] Group 2 - The report indicates that external demand may slow down in 2025, with oil prices under downward pressure due to OPEC+ increasing production [35][39] - Domestic demand is expected to stabilize and recover due to a series of incremental policies, with GDP growth projected at around 5% for the year [43][44] - The report highlights that the chemical raw materials and products industry fixed asset investment growth has significantly slowed, with the operating rate dropping to 73.5% in Q1 2025 [24][26] Group 3 - The report identifies potential investment opportunities in the chemical industry, particularly in supply-restricted sectors such as phosphate and potassium fertilizers, and in high-concentration sub-industries like viscose staple fiber and vitamins [48][49] - The report recommends focusing on companies involved in new materials, especially those related to import substitution, such as AI high-speed resins and fluorinated liquids [48][49] - The report suggests that the valuation of the basic chemical sector is at a historical low, with the overall PE and PB ratios at 22.29 times and 1.82 times respectively as of June 16, 2025 [52][53] Group 4 - The viscose staple fiber industry has not seen new capacity additions for several years, leading to a high concentration and potential for profit recovery [60][67] - The polyester industrial yarn sector is expected to see a reversal in supply and demand dynamics, with no new capacity planned and increasing demand from the automotive sector [69][79] - The modified plastics sector is projected to grow due to the ongoing replacement policies in domestic appliances and the rise of new demands from robotics and low-altitude applications [81][90] Group 5 - The refrigerant market is expected to grow steadily, supported by the ongoing replacement policies and increasing demand from the automotive sector [92][93] - The report highlights the potential for the civil explosives industry to see demand exceed expectations due to high resource prices and ongoing large-scale infrastructure projects [95][96] - The phosphate chemical sector is projected to maintain high profitability due to sustained high prices and tight supply-demand conditions [99][100]